Skip to main content

Elia Rojas Montserrat

Institutions of which they are part

Administration and Management
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Elia Rojas Montserrat

Institutions of which they are part

Administration and Management
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Maria Clemente Leon

Maria Clemente Leon

Main researcher
Growth and Development
Read more
Cristian Ariel González Cabrera

Cristian Ariel González Cabrera

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Inés Carolina Balón  Llerena

Inés Carolina Balón Llerena

Administration and Management
Molecular Imaging and Therapy
Read more
Eva María Pastor Arroyo

Eva María Pastor Arroyo

Research technician
Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.